Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cardiff Oncology (CRDF) Asset Utilization Ratio (2016 - 2025)

Cardiff Oncology's Asset Utilization Ratio history spans 14 years, with the latest figure at 0.01 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 10.44% year-over-year to 0.01; the TTM value through Dec 2025 reached 0.01, up 10.44%, while the annual FY2025 figure was 0.01, 2.4% down from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.01 at Cardiff Oncology, up from 0.01 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.01 in Q3 2024 and bottomed at 0.0 in Q3 2021.
  • The 5-year median for Asset Utilization Ratio is 0.0 (2023), against an average of 0.01.
  • The largest annual shift saw Asset Utilization Ratio crashed 86.01% in 2021 before it soared 135.05% in 2024.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.0 in 2021, then surged by 30.4% to 0.0 in 2022, then soared by 78.26% to 0.01 in 2023, then surged by 48.92% to 0.01 in 2024, then rose by 10.44% to 0.01 in 2025.
  • Per Business Quant, the three most recent readings for CRDF's Asset Utilization Ratio are 0.01 (Q4 2025), 0.01 (Q3 2025), and 0.01 (Q2 2025).